These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
296 related articles for article (PubMed ID: 30117265)
41. Sleep disorders and neuropsychiatric disorders in a pediatric sample of tuberous sclerosis complex: a questionnaire-based study. Moavero R; Voci A; La Briola F; Matricardi S; Toldo I; Mancardi MM; Negrin S; Messana T; Mazzone L; Valeriani M; Curatolo P; Bruni O Sleep Med; 2022 Jan; 89():65-70. PubMed ID: 34915263 [TBL] [Abstract][Full Text] [Related]
42. Real-World Evidence Study on the Long-Term Safety of Everolimus in Patients With Tuberous Sclerosis Complex: Final Analysis Results. Ruiz-Falcó Rojas ML; Feucht M; Macaya A; Wilken B; Hahn A; Maamari R; Hirschberg Y; Ridolfi A; Kingswood JC Front Pharmacol; 2022; 13():802334. PubMed ID: 35462939 [TBL] [Abstract][Full Text] [Related]
43. Psychiatric comorbidity and treatment response in patients with tuberous sclerosis complex. Chung TK; Lynch ER; Fiser CJ; Nelson DA; Agricola K; Tudor C; Franz DN; Krueger DA Ann Clin Psychiatry; 2011 Nov; 23(4):263-9. PubMed ID: 22073383 [TBL] [Abstract][Full Text] [Related]
44. The relationship of neuroimaging findings and neuropsychiatric comorbidities in children with tuberous sclerosis complex. Huang CH; Peng SS; Weng WC; Su YN; Lee WT; J Formos Med Assoc; 2015 Sep; 114(9):849-54. PubMed ID: 24698169 [TBL] [Abstract][Full Text] [Related]
45. Tuberous sclerosis complex: Concerns and needs of patients and parents from the transitional period to adulthood. Both P; Ten Holt L; Mous S; Patist J; Rietman A; Dieleman G; Ten Hoopen L; Vergeer M; de Wit MC; Bindels-de Heus K; Moll H; van Eeghen A Epilepsy Behav; 2018 Jun; 83():13-21. PubMed ID: 29631156 [TBL] [Abstract][Full Text] [Related]
47. The psychopathologies of children and adolescents with tuberous sclerosis complex (TSC): a postal survey of UK families. de Vries PJ; Hunt A; Bolton PF Eur Child Adolesc Psychiatry; 2007 Feb; 16(1):16-24. PubMed ID: 17268883 [TBL] [Abstract][Full Text] [Related]
52. Everolimus improves neuropsychiatric symptoms in a patient with tuberous sclerosis carrying a novel TSC2 mutation. Hwang SK; Lee JH; Yang JE; Lim CS; Lee JA; Lee YS; Lee K; Kaang BK Mol Brain; 2016 May; 9(1):56. PubMed ID: 27216612 [TBL] [Abstract][Full Text] [Related]
53. Genotype/phenotype in tuberous sclerosis complex: associations with clinical and radiologic manifestations. Kothare SV; Singh K; Hochman T; Chalifoux JR; Staley BA; Weiner HL; Menzer K; Devinsky O Epilepsia; 2014 Jul; 55(7):1020-4. PubMed ID: 24754401 [TBL] [Abstract][Full Text] [Related]
54. Empowering Families Through Technology: A Mobile-Health Project to Reduce the TAND Identification and Treatment Gap (TANDem). Heunis TM; Bissell S; Byars AW; Capal JK; Chambers N; Cukier S; Davis PE; De Waele L; Flinn J; Gardner-Lubbe S; Gipson T; Kingswood JC; Krueger DA; Kumm AJ; Sahin M; Schoeters E; Smith C; Srivastava S; Takei M; Vanclooster S; van Eeghen AM; Waltereit R; Jansen AC; de Vries PJ Front Psychiatry; 2022; 13():834628. PubMed ID: 35295772 [TBL] [Abstract][Full Text] [Related]
55. Psychiatric comorbid conditions in a clinic population of 241 patients with tuberous sclerosis complex. Muzykewicz DA; Newberry P; Danforth N; Halpern EF; Thiele EA Epilepsy Behav; 2007 Dec; 11(4):506-13. PubMed ID: 17936687 [TBL] [Abstract][Full Text] [Related]